Medicine and Dentistry
Nitric Oxide
90%
Cells
63%
Glucose
54%
Acetylsalicylic Acid
54%
Aminoguanidine
54%
Endothelial Cell
45%
Prostaglandin E2
36%
Development
27%
Lysine
27%
In Vitro
18%
Programmed Cell Death
18%
Hyperglycemia
18%
Retinopathy
18%
Diabetic Retinopathy
18%
Cell Type
9%
Drug Megadose
9%
Diabetes Mellitus
9%
Inducible Nitric Oxide Synthase
9%
Prostaglandin Synthase
9%
Prostaglandin
9%
Arginine Methyl Ester
9%
Retinal
9%
Glial Cell Line
9%
INIS
nitric oxide
100%
production
54%
glucose
54%
aspirin
54%
prostaglandins
45%
inhibition
36%
retina
27%
lysine
27%
bovine
27%
rats
18%
animals
18%
in vitro
18%
hyperglycemia
18%
apoptosis
18%
in vivo
9%
interactions
9%
viability
9%
doses
9%
esters
9%
arginine
9%
homogenates
9%
Pharmacology, Toxicology and Pharmaceutical Science
Nitric Oxide
90%
Acetylsalicylic Acid
54%
Glucose
54%
Aminoguanidine
54%
Prostaglandin E2
36%
Lysine
27%
NS-398
27%
Diabetes Mellitus
18%
Hyperglycemia
18%
Diabetic Retinopathy
18%
Animal
18%
Retinopathy
18%
Rat
18%
Prostaglandin Synthase
9%
Prostaglandin
9%
Arginine Methyl Ester
9%
Inducible Nitric Oxide Synthase
9%
Retinal
9%
Neuroscience
Nitric Oxide
90%
Glucose
54%
Aspirin
54%
Prostaglandin E2
36%
Lysine
27%
NS-398
27%
Retina
27%
In Vitro
18%
Hyperglycemia
18%
Diabetic Retinopathy
18%
Retinal Disease
18%
In Vivo
9%
Cell Line
9%
Diabetes
9%
Inducible Nitric Oxide Synthase
9%
Arginine Methyl Ester
9%
Retinal
9%
Prostaglandin
9%
Cyclooxygenase
9%
Glial Cells
9%
Veterinary Science and Veterinary Medicine
Aspirin
54%
Prostaglandin E2
36%
Retina
27%
NS-398
27%
Prostaglandin
9%
Cyclooxygenase
9%
Retinal
9%